Clinical Trial Update: Intravesical Chemotherapy Treatment of Superficial Bladder Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial by Eli Lilly evaluating intravesical chemotherapy for superficial bladder cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bladder Cancer

Snippet

Sponsor: Eli Lilly and Company | Conditions: Bladder Neoplasms | Phase 2 | Status: COMPLETED